Construction Of Danasome Factories Starts

Vietnam's US$1.4bn pharmaceutical market is one of the most promising in the Asia Pacific region. Annual per-capita spending is low (US$16.13) and growth is high - BMI is forecasting a compound annual growth rate of 17.95% through to 2013. Although the country is heavily reliant on medicine imports, this situation is changing as the local manufacturing sector

To read the full article, please sign in or take a free trial.